Navigation Links
2nd ESMO symposium on soft tissue carcinomas and GIST

Experts in treating a rare group of cancers that affect tissues such as muscle, fat, nerves and the gastrointestinal wall are meeting in Milan, Italy on 13-14 May to discuss the latest information on how these diseases develop and potential new avenues for therapy.

The 2nd Symposium on Sarcoma and GIST (Gastrointestinal Stromal Tumors) organized by the European Society for Medical Oncology (ESMO), will include sessions on the genetics of sarcomas, on understanding how drug resistance develops and possibilities for new treatment options.

There will be a particular focus on how scientists and clinicians can work together to develop new treatments, including molecular targeted therapies. The theme of the meeting is 'Insights at the crossroads of molecular biology, pathology and clinic.'

"Sarcomas are relatively rare, but they are serving as a model for the way new molecular targeted therapies are being introduced into clinical practice," said co-chair of the event Dr. Paolo G. Casali, Head of the Sarcoma Medical Treatment Unit at the Milan Istituto Nazionale Tumori and Chair of the ESMO Sarcoma Working Group. "This challenges our ability to combine information from as diverse areas as biology, pathology and the clinic to achieve better results for patients."

"The molecular and pathological bases represent extremely valuable diagnostic and prognostic information for the proper treatment of this disease, although the way we can exploit all these data in the clinic is still to be defined properly," said co-chair Dr. Paolo Dei Tos, Director of the Pathology Unit of the Regional Hospital of Treviso, Italy.

Sarcomas are cancers of the connective or supportive tissues, such as muscles, tendons, ligaments, nerves, fat and blood vessels, therefore they can arise everywhere in the body, although they are rare. Sarcomas are also different to the much more frequent carcinomas of the breast, colon, lung, and others.

Around 50 different kinds of soft-tissue sarcomas have been identified, affecting around 4 new patients per 100,000 in the population each year. Gastrointestinal stromal tumors, a specific subtype of sarcoma that affects the wall of the stomach and intestine, affect 1.5 new patients per 100,000 people each year.

Among the top clinical and translational researchers who will speak at the symposium there are L. Baker, R. Benjamin, E. de Alava, P. Hogendoorn, G. Demetri, J. Fletcher, L. Helman, M. Ladanyi, R. Maki.

The highly qualified Symposium Faculty, made up of some of the most eminent experts in the field of sarcoma treatment and research, has also organized a two-day closed meeting before the event to discuss ideas for future research projects.

The ESMO Symposium on Sarcoma and GIST is supported by two pharmaceutical companies -- Novartis Oncology and PharmaMar -- and by Conticanet, a EU-funded project for clinical research on soft tissue sarcomas in Europe, whose coordinator, Dr. Jean-Yves Blay, is one program co-chair. The event has been organized also in cooperation with the Milan Istituto Nazionale Tumori, a referral institute for sarcomas and GIST.

"ESMO is dedicated to educating and supporting oncologists, also when it comes to the treatment of specific disease areas such as sarcoma," said Prof. Rolf A. Stahel, Chair of the ESMO Educational Committee.

In line with its commitment to educate and guarantee the best possible treatment to all cancer patients, later this year ESMO will be hosting an event dedicated to rare tumors in Brussels, 'Rare Tumors in Europe: Challenges and Solutions'.

"Sarcomas being rare cancers make this meeting a significant expression of ESMO's efforts on rare diseases," said Dr. Casali. Rare tumors are classified as such if considered individually, but represent collectively one-fourth of all cancer cases. "People with rare diseases have the same right to receive proper treatment as all other patients", he added, "which is why it is important that a pan-European organization like ESMO is active in this field."


Contact: Vanessa Pavinato
European Society for Medical Oncology

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
3. NARSAD - Worlds Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th
4. XShares Supports Parkinsons Disease Foundation 50th Anniversary Educational Symposium
5. Poll Shows Voters Want Long Term Care Included in Presidential Candidates Healthcare Proposals, Released at 2007 National Long Term Care Symposium
6. Cosmetic Bootcamp Solidifies Lead as Investor Symposium for Aesthetic Medicine
7. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
8. AMIAs 31st Annual Symposium Opens in Chicago, IL
9. Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation
10. Aesthetic Extender Symposium, LLC Announces its Inaugural Event
11. New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS)
Post Your Comments:
(Date:12/1/2015)... Wilmington, Delaware (PRWEB) , ... December 01, 2015 ... ... award winner at the 7th Annual 2015 Golden Bridge Business Awards under the ... is a zero capex web based sample management software that ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... quantification and optimization of adjunctive imaging is the focus of numerous abstracts accepted ... meeting, November 29-December 4, 2015. Nine abstracts highlight the use of Volpara ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Excellence (BHCOE) today announced that the organization has awarded Education and Developmental Therapies ... a Distinguished Award. The award celebrates exceptional special needs providers that excel in ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... ... ... With FCPX Overlay: Grit , users can apply a grit effect ... truly endless, all with a click of a mouse. Each user has full control ... of field and more, all within Final Cut Pro X. , With FCPX Overlay: ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , 1 de diciembre de 2015 /PRNewswire/ ... para cuchillas de precisión, develó hoy un ... identidad de marca. El nuevo logo destaca ... y la ingeniería de productos con cuchillas ... ...
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
Breaking Medicine Technology: